Beyond Hyperglycemia: The Role of Sodium–Glucose Cotransporter 2 Inhibitors in Cancer Treatment-related Cardiac Dysfunction

US Cardiology Review · Published 2026-08-03 · DOI 10.15420/usc.2025.20

Free full text

Authors (7)

Rebecca S Steinberg, Ritika Tuli, Shivani Reddy, Rafael Toro-Manotas, Natalie Marrero, Dinu V Balanescu, Manu Murali Mysore

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Steinberg, R., Tuli, R., Reddy, S., et al. (2026). Beyond Hyperglycemia: The Role of Sodium–Glucose Cotransporter 2 Inhibitors in Cancer Treatment-related Cardiac Dysfunction. US Cardiology Review. https://doi.org/10.15420/usc.2025.20

Related articles

• Assessing Invasive Coronary Angiography Interpretation Education and Resources · US Cardiology Review · 2025 · Same journal
• A Right-atrial Variant of Wild-type Transthyretin Cardiac Amyloidosis · US Cardiology Review · 2025 · Same journal
• Point-of-care Ultrasound Assessment of the Internal Jugular Vein During Bending in Healthy Individuals · US Cardiology Review · 2025 · Same journal
• Remote Monitoring in Heart Failure: Revolutionizing Patient Management and Outcomes · US Cardiology Review · 2024 · Same journal
• Aortic Endograft Infection: Timely Recognition Is Key · US Cardiology Review · 2025 · Same journal
• Extracorporeal Cardiopulmonary Resuscitation: Life-saving or Resource Wasting? · US Cardiology Review · 2024 · Same journal
• Navigating Digital Medical Education in the Current Era: Process Over Platform · US Cardiology Review · 2025 · Same journal
• Risk Factors for Aortic Dissection · US Cardiology Review · 2023 · Same journal
• From Abdomen to Atrium: Myxoma Found Incidentally Causing Severe Functional Mitral Stenosis · US Cardiology Review · 2025 · Same journal
• Outcomes of Complex Percutaneous Cardiac Interventions in Women · US Cardiology Review · 2023 · Same journal